The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?

2 September 2024 (09:00 - 09:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Matteo Beltrami

Careggi, Florence (Italy)

7 More presentations in this session

Presentation thumbnail

Predictors of Right vEntricular Failure aftER LVAD implantation: PREFER LVAD study

Associate Professor M. Cameli (Siena, IT)

Abstract Slides Video

Presentation thumbnail

Elevated cancer biomarkers in patients with severe heart failure could be a potential predictor of mortality during LVAD support

Doctor A. Bielka (Zabrze, PL)

Abstract Slides Video

Presentation thumbnail

Right ventricular failure following left ventricular assist device implantation.

Associate Professor M. Laimoud (Riyadh, SA)

Abstract Slides Video

Presentation thumbnail

Optimal anticoagulation strategy for left ventricular assist device patients undergoing thoracentesis: a retrospective study

Doctor S. Hegde (Charlotte, US)

Abstract Slides Video

Presentation thumbnail

A meta-analysis of the efficacy and safety of exercise-based cardiac rehabilitation in patients with left ventricular assist devices.

Doctor M. Abouzid (Poznan, PL)

Abstract Slides Video

Access the full session

Session thumbnail

Devices in heart failure: new findings

The Event

Event poster

ESC Congress 2024

2 September 2024 09:00 CET

You may be interested in

Congress Presentation

Cardiac resynchronization therapy - beyond ejection fraction

Congress Presentation

Long-term outcome in non-progressors to cardiac resynchronization therapy

Congress Presentation

Re-classification of response to cardiac resynchronization therapy: the long-term effect of echocardiographic non-progression

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources